What is the fair value of LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) stock?

The current fair value estimate for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is $29.84. This implies an estimated upside of 29.7% versus the current market price.

Is LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 29.7% versus the current market price.

How is the financial health of LifeMD Inc Preferred Series A?

The current financial health read for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is LifeMD Inc Preferred Series A's next earnings date?

The next earnings date currently listed for LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is November 6, 2026.

Does LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) pay dividends?

Based on the current data, dividend yield is 9.6%.

What is the market capitalization of LifeMD Inc Preferred Series A?

The current market capitalization listed for LifeMD Inc Preferred Series A is 155.4 M.

What is the enterprise value of LifeMD Inc Preferred Series A?

The current enterprise value listed for LifeMD Inc Preferred Series A is 136.1 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for LifeMD Inc Preferred Series A?

The ticker symbol for LifeMD Inc Preferred Series A is NASDAQ-LFMD.P, and the stock is listed on NASDAQ.

Where is LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) listed?

LifeMD Inc Preferred Series A (NASDAQ-LFMD.P) is listed on NASDAQ.

What is the debt-to-total-capital ratio for LifeMD Inc Preferred Series A?

The current debt-to-total-capital ratio listed for LifeMD Inc Preferred Series A is 3.8%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for LifeMD Inc Preferred Series A?

The free float listed for LifeMD Inc Preferred Series A is 82.3%. Free float helps investors understand how much of the share base is available for public trading.

LifeMD Inc Preferred Series A (LFMDP) Fair Value & Stock Analysis...

LifeMD Inc Preferred Series A (LFMDP)

LifeMD Inc Preferred Series A (NASDAQ: LFMD.P) is a preferred security linked to LifeMD, Inc., a direct-to-patient telehealth company based in New York, New York. The underlying business provides virtual medical care and pharmacy-related services in the United States through a telehealth platform that includes Rex MD, a men’s health service, ShapiroMD, which focuses on hair-loss treatment, and LifeMD PC, a virtual primary care and telehealth offering. Its services also include on-demand consultations, prescriptions, diagnostics and imaging, wellness coaching, in-home tools integration, GLP-1 weight-management support, and in-home health monitoring devices. Founded in 1994, the company was formerly known as Conversion Labs, Inc. and adopted the LifeMD name in February 2021.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NASDAQ-LFMD.P	$29.84	29.7% Upside	Undervalued	Not available	Not available	Fair	9.6%	November 6, 2026	19.5x	0.8x	155.4 M	136.1 M	3.8%	82.3%	-2.8	1,545.3%	31.5%